BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
110 results:

  • 1. Nortriptyline hydrochloride, a potential candidate for drug repurposing, inhibits gastric cancer by inducing oxidative stress by triggering the Keap1-nrf2 pathway.
    Zhu C; Lu Y; Wang S; Song J; Ding Y; Wang Y; Dong C; Liu J; Qiu W; Qi W
    Sci Rep; 2024 Mar; 14(1):6050. PubMed ID: 38480798
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Overexpression of nrf2 reverses ferroptosis induced by Arenobufagin in gastric cancer.
    Long J; Wang W; Chu J; Li Y; Wang M; Su J; Yang Y; Wang G; Li Q; Cheng H
    Toxicol Appl Pharmacol; 2024 Mar; 484():116842. PubMed ID: 38307257
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acyltransferase zinc finger DHHC-type containing 2 aggravates gastric carcinoma growth by targeting nrf2 signaling: A mechanism-based multicombination bionic nano-drug therapy.
    Liu L; Wang L; Liu L; Qu X; Zhao W; Ding J; Zhao S; Xu B; Yu H; Liu B; Chai J
    Redox Biol; 2024 Apr; 70():103051. PubMed ID: 38301594
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Proapoptotic effect of WS-299 induced by NOXA accumulation and nrf2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.
    Ma T; Song Q; Cheng B; Guo E; Wang X; Li M; Dai M; Li S; Feng S; Yu B
    Bioorg Chem; 2024 Mar; 144():107142. PubMed ID: 38280358
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Kong W; Liu X; Zhu H; Zheng S; Yin G; Yu P; Shan Y; Ma S; Ying R; Jin H
    Aging (Albany NY); 2024 Jan; 16(2):1767-1780. PubMed ID: 38244583
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and nrf2/GPX4 Axes.
    Ding L; Dang S; Sun M; Zhou D; Sun Y; Li E; Peng S; Li J; Li G
    Free Radic Biol Med; 2024 Mar; 213():150-163. PubMed ID: 38190923
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of ferroptosis by POLE2 in gastric cancer cells involves the activation of nrf2/GPX4 pathway.
    Jian H; Chen ZQ; Du H; Liao T; Sun YC; Ke D; Yu Y
    J Cell Mol Med; 2024 Jan; 28(1):e17983. PubMed ID: 38070189
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Natural products for gastric carcinoma prevention and treatment: Focus on their antioxidant stress actions in the Correa's cascade.
    Guo C; Wan L; Li C; Wen Y; Pan H; Zhao M; Wang J; Ma X; Nian Q; Tang J; Zeng J
    Phytomedicine; 2024 Jan; 123():155253. PubMed ID: 38065034
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/nrf2/GPX4 axis.
    Huang W; Wen F; Yang P; Li Y; Li Q; Shu P
    Phytomedicine; 2024 Jan; 123():155220. PubMed ID: 38056149
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Metabolic and immune-related gene signatures: Predictive stratification and prognostic implications in gastric cancer.
    Shao J; Zhang W; Li Y; Tang Y; Fan L
    J Gene Med; 2024 Jan; 26(1):e3635. PubMed ID: 37984993
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Allyl isothiocyanate induces DNA damage and inhibits DNA repair-associated proteins in a human gastric cancer cells in vitro.
    Shih YL; Hsu SY; Lai KC; Chueh FS; Huang YL; Kuo CL; Chen YL; Chen CJ; Peng SF; Huang WW; Lu HF
    Environ Toxicol; 2024 Mar; 39(3):1303-1314. PubMed ID: 37966020
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human gastric cancer Organoids as Stem Cell Therapy Model.
    Wu DC; Ku CC; Pan JB; Wuputra K; Yang YH; Liu CJ; Liu YC; Kato K; Saito S; Lin YC; Chong IW; Hsiao M; Hu HM; Kuo CH; Kuo KK; Lin CS; Yokoyama KK
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958895
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparison with gastric cancer-associated genes reveals the role of ferroptosis-related genes in eosinophils of asthma patients: A bioinformatic study.
    Niu J; Guo W; Lu A; Han G; Wang G; Peng B; Zhao J
    Medicine (Baltimore); 2023 Oct; 102(41):e35002. PubMed ID: 37832131
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer.
    Gupta J; Ahmed AT; Tayyib NA; Zabibah RS; Shomurodov Q; Kadheim MN; Alsaikhan F; Ramaiah P; Chinnasamy L; Samarghandian S
    Biomed Pharmacother; 2023 Oct; 166():115337. PubMed ID: 37659203
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].
    Huang XM; Zhang K; Yin J; Wu PF; Cai BB; Lu ZP; Tu M; Chen JM; Guo F; Xi CH; Wei JS; Wu JL; Gao WT; Dai CC; Miao Y; Jiang KR
    Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):894-900. PubMed ID: 37653992
    [No Abstract]    [Full Text] [Related]  

  • 16. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/nrf2 pathway.
    Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
    Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Role of CDK20 Protein in Carcinogenesis.
    Chivukula S; Malkhed V
    Curr Drug Targets; 2023; 24(10):790-796. PubMed ID: 37469151
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis.
    Yang Z; Zou S; Zhang Y; Zhang J; Zhang P; Xiao L; Xie Y; Meng M; Feng J; Kang L; Lee MH; Fang L
    Nat Commun; 2023 Jul; 14(1):4193. PubMed ID: 37443154
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The putative role of ferroptosis in gastric cancer: a review.
    Wang L; Wang H
    Eur J Cancer Prev; 2023 Nov; 32(6):575-583. PubMed ID: 37318883
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.